You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Bavituximab

Showing 1 - 25 of 27
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Hepatocellular Carcinoma Trial in Dallas (Axitinib, Avelumab, Bavituximab)

Not yet recruiting
  • Hepatocellular Carcinoma
  • Dallas, Texas
    The University of Texas Southwestern Medical Center
Jun 27, 2022

Hepatocellular Carcinoma Trial in Dallas (Pembrolizumab, Bavituximab)

Recruiting
  • Hepatocellular Carcinoma
  • Dallas, Texas
    University of Texas Southwestern Medical Center
Apr 27, 2022

Squamous Cell Carcinoma Trial in Baltimore (Bavituximab, Pembrolizumab)

Recruiting
  • Squamous Cell Carcinoma
  • Baltimore, Maryland
    University of Maryland Medical Center
Mar 17, 2022

Glioblastoma Trial in Boston (Temozolomide, Bavituximab, Radiation)

Active, not recruiting
  • Glioblastoma
  • Boston, Massachusetts
  • +1 more
Oct 27, 2021

Gastric Cancer, GastroEsophageal Cancer Trial in Worldwide (Bavituximab, Pembrolizumab Injection)

Active, not recruiting
  • Gastric Cancer
  • GastroEsophageal Cancer
  • Bavituximab
  • Pembrolizumab Injection
  • New Haven, Connecticut
  • +20 more
Jun 14, 2022

Hepatocellular Carcinoma, Liver Cancer Trial in Dallas (bavituximab (0.3 mg/kg) and sorafenib, bavituximab (1.0 mg/kg ) and

Completed
Has Results
  • Hepatocellular Carcinoma
  • Liver Cancer
  • bavituximab (0.3 mg/kg) and sorafenib
  • +2 more
  • Dallas, Texas
    UT Southwestern Medical Center
Oct 22, 2020

Rectal Adenocarcinoma Trial in Dallas (Radiation, Bavituximab, Capecitabine)

Completed
  • Rectal Adenocarcinoma
  • Radiation
  • +2 more
  • Dallas, Texas
    University of Texas Southwestern Medical Center
Aug 19, 2020

HepatoCellular Carcinoma, Unresectable HepatoCellular Carcinoma, Liver Cancer Trial in Tampa (Stereotactic Body Radiation

Withdrawn
  • HepatoCellular Carcinoma
  • +2 more
  • Stereotactic Body Radiation Therapy (SBRT)
  • +2 more
  • Tampa, Florida
    H. Lee Moffitt Cancer Center and Research Institute
Jun 3, 2020

Non Small Cell Lung Cancer (NSCLC) Trial in Chapel Hill, Pittsburgh (Bavituximab)

Completed
  • Non Small Cell Lung Cancer (NSCLC)
  • Bavituximab
  • Chapel Hill, North Carolina
  • +1 more
Dec 3, 2018

Prostate Cancer, Prostatic Tumors Trial in Charleston (Cabazitaxel plus bavituximab)

Terminated
Has Results
  • Prostate Cancer
  • Prostatic Neoplasms
  • Cabazitaxel plus bavituximab
  • Charleston, South Carolina
    Medical University of South Carolina
Jun 15, 2018

Metastatic Breast Cancer Trial in Bakersfield, Tinley Park (Bavituximab, Taxane)

Withdrawn
  • Metastatic Breast Cancer
  • Bakersfield, California
  • +1 more
Jul 7, 2017

Breast Cancer Trial in Georgia (Bavituximab)

Completed
  • Breast Cancer
  • Bavituximab
  • Lisi Lake, Tbilisi, Georgia
  • +3 more
Apr 19, 2017

Breast Cancer, Triple Negative Breast Tumors, Triple-Negative Breast Tumor Trial (Bavituximab, Taxane)

Withdrawn
  • Breast Cancer
  • +6 more
  • (no location specified)
Mar 8, 2017

Metastatic Pancreatic Cancer Trial in Ukraine, United States (bavituximab, Gemcitabine)

Completed
  • Metastatic Pancreatic Cancer
  • Chandler, Arizona
  • +18 more
Apr 18, 2017

Melanoma Trial in Dallas (Arm A-Bavituximab 3mg/kg IV over 90 minutes weekly x 3 followed by Bavituximab 3mg/kg IV over 90

Terminated
  • Melanoma
  • Arm A-Bavituximab 3mg/kg IV over 90 minutes weekly x 3 followed by Bavituximab 3mg/kg IV over 90 minutes weekly x 12 plus ipilimumab 3mg/kg IV
  • Arm B-Ipilimumab 3mg/kg IV over 90 minutes day 1 followed three weeks later by ipilimumab every 3 weeks x 3.
  • Dallas, Texas
    University of Texas Southwestern Medical Center
Dec 28, 2016

Non-Squamous NSCLC Trial in Worldwide (Paclitaxel / Carboplatin, bavituximab)

Completed
  • Non-Squamous Non-Small Cell Lung Cancer
  • Paclitaxel / Carboplatin
  • bavituximab
  • Chandler, Arizona
  • +39 more
Apr 18, 2017

Non-small-cell Lung Cancer Trial in Worldwide (Docetaxel plus bavituximab or )

Completed
  • Non-small-cell Lung Cancer
  • Docetaxel plus bavituximab or placebo
  • Chandler, Arizona
  • +52 more
Apr 18, 2017

NSCLC Trial (durvalumab, bavituximab)

Withdrawn
  • Non-Small Cell Lung Cancer
  • durvalumab
  • bavituximab
  • (no location specified)
Jul 28, 2016

Non-Small-Cell Lung Cancer Stage IIIB, Non-Small-Cell Lung Cancer Stage IV, Non-Small-Cell Lung Cancer Metastatic Trial in

Completed
  • Non-Small-Cell Lung Cancer Stage IIIB
  • +6 more
  • bavituximab
  • +2 more
  • Huntsville, Alabama
  • +160 more
Apr 19, 2017

Human Epidermal Growth Factor 2 Negative Carcinoma of Breast, Male Breast Cancer, Recurrent Breast Cancer Trial in Tucson (drug,

Completed
  • Human Epidermal Growth Factor 2 Negative Carcinoma of Breast
  • +4 more
  • Tucson, Arizona
    Arizona Cancer Center
Apr 20, 2016

Hepatitis C Trial in Tbilisi (Bavituximab, Pegylated interferon (PEG-IFN))

Completed
  • Hepatitis C
  • Bavituximab
  • Pegylated interferon (PEG-IFN)
  • Tbilisi, Georgia
    LTD Vakhtang Bochorishvili Anticeptic Centre
Feb 2, 2012

Hepatitis C Virus, Hiv Infections Trial in United States (bavituximab)

Completed
  • Hepatitis C Virus
  • Hiv Infections
  • bavituximab
  • Los Angeles, California
  • +5 more
Jun 7, 2011

Carcinoma Breast Stage IV Trial in India (Bavituximab)

Completed
  • Carcinoma Breast Stage IV
  • Bavituximab
  • Bangalore, India
  • +8 more
Mar 23, 2011

NSCLC Trial in India (bavituximab plus paclitaxel and carboplatin)

Completed
  • Non-small Cell Lung Cancer
  • bavituximab plus paclitaxel and carboplatin
  • Bannerghatta Rd., Banglore, India
  • +8 more
Mar 23, 2011

Tumors Trial in United States (Bavituximab)

Completed
  • Tumors
  • Bavituximab
  • Tucson, Arizona
  • +5 more
Feb 28, 2011